Emerging Nucleic Acid Cargos for Next-Generation RNA Vaccines and Therapeutics
Bioconjugate Chemistry · 2025
DOI: 10.1021/acs.bioconjchem.5c00476 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioconjugate Chemistry, 2025. Verfasst von Hannah C Safford und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Hauptthemen laut MEDLINE: mRNA Vaccines, Nucleic Acids. Die Arbeit nennt 54 Literaturangaben. Gefördert von: NICHD NIH HHS, NHLBI NIH HHS, National Science Foundation Graduate Research Fellowship Program.
Abstract (Originalsprache)
Messenger RNA (mRNA) lipid nanoparticles (LNPs) have emerged as a transformative technology with broad applications in vaccines, protein replacement therapy, and gene editing. However, the transient nature of mRNA expression often necessitates high or repeated dosing regimens, limiting its therapeutic potential. Thus, there is a critical need for innovation at the interface of RNA biology and drug delivery that prolong the duration of RNA translation. In this Viewpoint, we provide an overview of emerging nucleic acid cargos that address these challenges, specifically self-amplifying RNA (saRNA) and circular RNA (circRNA), and provide a framework for how these nucleic acid cargos can enable the next generation of vaccines and therapeutics for diverse clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Center for Fetal Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States.
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), Republic of Singapore, 138669, Singapore.
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
ORCID-Profile: Hannah C Safford, Rohan Palanki, Michael J Mitchell
Förderung
- NICHD NIH HHS
- NHLBI NIH HHS
- National Science Foundation Graduate Research Fellowship Program
- Agency for Science, Technology and Research
- National Heart, Lung, and Blood Institute
- National Institute of Child Health and Human Development
- American Cancer Society
- Division of Chemical, Bioengineering, Environmental, and Transport Systems
Zitieren
APA
Safford, H. C., Palanki, R., Ang, M., & Mitchell, M. J. (2025). Emerging Nucleic Acid Cargos for Next-Generation RNA Vaccines and Therapeutics. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.5c00476
Vancouver
Safford HC, Palanki R, Ang M, Mitchell MJ. Emerging Nucleic Acid Cargos for Next-Generation RNA Vaccines and Therapeutics. Bioconjugate Chemistry. 2025. doi:10.1021/acs.bioconjchem.5c00476
BibTeX
@article{Safford2025,
author = {Safford, Hannah C and Palanki, Rohan and Ang, Melgious and Mitchell, Michael J},
title = {Emerging Nucleic Acid Cargos for Next-Generation RNA Vaccines and Therapeutics},
journal = {Bioconjugate Chemistry},
year = {2025},
doi = {10.1021/acs.bioconjchem.5c00476}
}
EUVIMED